---
title: Development of the Lee Symptom Scale-Skin Sclerosis for chronic GVHD-associated
  sclerosis
date: '2025-01-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39808799/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20250115170812&v=2.18.0.post9+e462414
source: Blood
description: Sclerosis is a highly morbid manifestation of chronic GVHD (cGVHD), associated
  with distressing symptoms and significant long-term disability. A patient-reported
  outcome measure (PRO) for cGVHD-associated sclerosis is essential to advance therapeutic
  trials. We aimed to develop a PRO for adults with cGVHD-associated sclerosis and
  evaluate and refine its content validity. Adults age ≥18 years with cGVHD-associated
  sclerosis participated in semi-structured interviews to identify salient ...
disable_comments: true
---
Sclerosis is a highly morbid manifestation of chronic GVHD (cGVHD), associated with distressing symptoms and significant long-term disability. A patient-reported outcome measure (PRO) for cGVHD-associated sclerosis is essential to advance therapeutic trials. We aimed to develop a PRO for adults with cGVHD-associated sclerosis and evaluate and refine its content validity. Adults age ≥18 years with cGVHD-associated sclerosis participated in semi-structured interviews to identify salient ...